highlights

Managing Shortages: switch from reactivity to proactivity

Medicine shortages threaten therapeutic continuity and call for a shift in approach—from reactive to proactive. The AFI study group analyzes global and local causes, proposing prevention strategies based on the FMEA methodology to make companies more resilient, aware, and capable of leading change.

Artificial Intelligence and Pharmaceutical Chemistry

A study shows that transformer-based chemical language models can transform molecular cores and substituents into novel and diverse compounds. The generated molecules exhibit good synthetic accessibility and potential biological relevance, with significant implications for drug design.

Business

Genitourinary Tumor Study ongoing with Active Screening and Enrollment

Genenta announces Long-Term follow-up observations in brain tumor (GBM) study with emerging survival signals

CE marking for substance-based medical devices and drug-device combination products

BSI, full-scope Notified Body for all three types of devices pursuant to MDR and IVDR, is able to offer verification services for compliance with European directives about the production of medical devices

MAGAZINE

MakingPharmaIndustry | March 2025 | Issue 1

In the March multimedia magazine, we explore the impact of artificial intelligence and cybersecurity regulations in the pharmaceutical industry. As artificial intelligence reshapes drug development,...

MakingPharmaIndustry | The Magazine of the Pharma World | Issue 1_2025

This special issue explores the impact of automation and AI on pharmaceutical production—across GxP, sustainability, and digitalization.
spot_img
spot_img
spot_img
spot_img
spot_img